#EEG Devices Market

[sunil-jad]

EEG Devices Market Key Companies Profile, Supply, Demand and SWOT Analysis

The Insight Partners offers investors a comprehensive study of the EEG Devices Market from the perspective of entrepreneurs in their most recent research report, " EEG Devices Market Share, Size and Trends Analysis | 2030." Examining current market conditions yields insightful information for businesses.

This report provides insights into market possibilities, obstacles, and incentives that companies shouldn't pass up. It would be a company recipe for success to choose a EEG Devices market research since consumer-centric firms often provide higher returns on investment. Making a small batch of items won't be enough, given the intense competition in the EEG Devices market. Businesses may estimate a product's potential and success with the use of market research.

What are areas in focus in this market research?

1) Overview of Business Environment - Numerous elements that characterize the EEG Devices market are examined in this chapter, including opportunities, dangers, limitations, and drivers. Genuine market determinants foster innovation. The distribution of company activity and the factors influencing development are the main topics of this section. A wide range of market-specific data is offered, making it possible to make an initial determination of the market's potential.

2) Competitive Comparison Matrix - The goal of this market research chapter in EEG Devices market report is to provide businesses with a competitive comparison matrix. This section provides a comprehensive overview of rivals' business strategies and scale-ups. Businesses can use in-depth market research and target market insights to identify rivals' alternatives. Through studying rivals' offers, businesses might find new market segments and sales channels.

Key companies in the EEG Devices market are- , Brain Products GmbH, g.tec medical engineering GmbH, Cognionics, Inc., Wearable Sensing, Neuroelectrics, ANT Neuro, Mitsar Co. Ltd., Neurosky, Biosemi, Advanced Brain Monitoring, Inc., EMOTIV, MUSE, Koninklijke Philips N.V., Bitbrain Technologies, ..

3) Briefing on COVID-19 impact - The COVID-19 pandemic disrupted supply and demand worldwide. EEG Devices Market participants had to contend with poor marketing performance, lower revenues, and difficulties surviving their manufacturing lifecycles. Lockdowns and transportation limitations created a distribution channel crisis for businesses at the same time. Maintaining supply-demand balance and controlling expectations proved to be difficult for small and medium-sized businesses. An examination of COVID-19's effects on companies and alternate strategies they have employed to deal with the interruptions caused by the epidemic. This chapter also discusses the potential for recovery following COVID-19.

4) High ROI Trade Offs – To effectively serve their consumers in a competitive EEG Devices market, businesses must educate themselves about important categories. Streamlining market tactics is a potent use of market research. The product, application, and regional categories are highlighted in this study area. Comprehending demographics and high-return-on-investment (ROI) regional regions facilitates brands in optimizing their offerings.

EEG Devices Market Segmentation

Based on Product this market is categorized further into -

8-channel EEG

21-channel EEG

25-channel EEG

32-channel EEG

40-channel EEG

Multi-channel EEG

Based on Application this market is categorized further into -

Sleep Disorders

Neuroscience

Head Trauma

Brain Tumors

Others

Based on Device Type this market is categorized further into -

Standalone Devices

Portable Devices

Based on End user this market is categorized further into -

Hospitals & Clinics

Diagnostic Centers

Academic & Research Institutes

Research Centers

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World…

How can this research help you in getting business strategically Correct?

Exact valuation and key facts about the market

Value proposition analysis that helps businesses revise their offerings timely

Marketing and segmentation strategies for new entrants in the market

Competitive growth strategies for market participants

Latest trends and technologies in the market

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.

[iminseriousdebt]

GENLOSS RAMBLE

Heyo! This is a little ramble I needed to make before the founders cut comes out!  yipee!

(GENERATION LOSS SPOILERS)

/

/

/

/

/

/

/

/

/

/

/

/

/

/

/

/

So we can see in the above images the methods Showfall Media is using to control gl!Sneeg gl!Charlie and gl!Ranboo, they use an already pre-existing technology called an Electroencephalogram (EEG). Now this technology has been in use for decades, and essentially how it works is that it uses electrodes placed onto your scalp combined with a conductive gel to measure the electrical activity in your brain, these electrical signals are usually referred to as “brain waves” and these brainwaves can be subdivided into four categories, Gamma (greater than 30 Hz), Beta (13-30 Hz), Alpha (8-12 Hz), Theta (3.5-7.5 Hz), and Delta (0.1-3.5 Hz)

These different brainwaves are generally assosiated with different emotions, awareness levels, brain activities, etc. Now if Showfall Media has installed these onto sneeg, charlie, and ranboo, that means they have access to their thoughts and feelings, but brainscanning isn’t an absolute precise device, it still takes a lot of human effort and time to properly interpret the brainwaves. If Showfall somehow had a tool to easily interpret the signals they could much more easily operate, say, a live show. Lucky for them there is already a real life solution to this problem, kinda.

Its called Brain Generative Pre-Training Transformer, or BrainGPT for short.  What its goal is, is to act as an assist tool for human neurologists to use in real neuroscience cases and case studies, what it does is it uses a Large Language Model (LLM) full of pre-existing human research papers and other neuroscience knowledge too vast for human comprehension. And whenever a neurologist hands BrainGPT a prompt, (such as anomalous finding or to asses the fields understanding of a certain topic) , “would generate likely data patterns reflecting its current synthesis of the scientific literature”  (braingpt.org)

Now in regards to Generation Loss, what this means is that Showfall Media potentially has acces to this sort of technology, and would be able to use it in the production of their shows, now BrainGPT has a good way to go before its widely avalable. But in the genloss au, it can be far into development at this point, and be available for companies to use in whatever way they see fit.

Now reading and decoding brain signals is one thing, but to mind control someone is far beyond what is capable today, but Showfall Media has somehow developed technology to do so, the way I’m guessing they did it is that they produced certain brainwaves from the electrodes on the actors heads to give them the emotional reactions they needed for the show. I can’t exactly get into the technical stuff cause I’m not a neurologist, but its just a hunch on how I think they did it.

As for the mind controlling devices themselves, I feel there’s a more subtextual reason as to why those objects in particular are chosen as the devices that are central to the show’s operation. Ranboo’s mask has been a heavy emphasis throughout Gen 1 TSE,

Its been a central figure in not only generation loss’ marketing, but also ranboo’s marketing, because when you think of ranboo one of the first things that pops up is the mask, atleast in the wider public’s eye.

But these general associations not only exist with Ranboo, with Slimcicle you usually think of the wide brim glasses, with Sneeg its his backwards cap, and this is with the other cast members too when their introduced on the spinning carousel in episode 2. Furthermore, with Niki it’s that’s she's just so nice, with Austin its that he’s just a gay guy,  and with Vinny and Ethan these associations don’t really exist. So, with Vinny he's just the “hoarder”, and Ethan isn't even introduced. And then there's Jerma, who is relinquished to a goofy character with a weird voice and a strange sense of humour which sort of fits his public image.

But what I wanna mention with Ranboo’s mask specifically is that with the three images shown on the genloss twitter of the control devices, sneeg’s is just a hat, like theres nothing special about it, just a hat with electrodes on it, when you take it off he’s completely in control of himself. But, with charlie’s it’s a good bit harder to just take it off. His glasses are drilled into his skull connected to electrodes which are also implanted in his skull, with an additional feature of a speaker in his jaw. But if you remove the glasses, there would be a lot of bleeding and his vision would be impaired, but he would still be a free man.

But with Ranboo, poor, poor, Ranboo… Like Charlie, they have electrodes implanted on to their brain connected to a switch on the back of their skull (which also may or may not also be connected to their spine, idk its hard to tell). These sprout wires that thread through the mask and lead into their throat, and the mask piece itself is sewn shut onto their SKIN.

Now this makes me wonder, why is Ranboo so heavily guarded when the other are (relatively) easy to set free? Is it because Ranboo is an integral part of the show and therefore high risk? Is it because Showfall needed extra resources for the chat to be able to control them?... Or is it because Ranboo tried to escape so many times before that they were forced to disfigure them to such an extreme degree, and yet somehow, SOMEHOW, they are able to resist, whether it be tapping SOS on their hand when they're on full control mode or shanking a Showfall employee with a dagger, Ranboo, Resists. But Showfall will never let them leave. Or they will? Idk founders cut hasn’t come out yet as of writing this, anyway ramble over. You can leave now.

[insightfulblogz]

Epilepsy Surgery Market Outlook, Size, Growth, Price, Latest Trends & Industry Forecast 2032

Epilepsy surgery is a transformative treatment option for individuals with drug-resistant epilepsy, offering a chance to significantly reduce or eliminate seizures. This surgical intervention targets the area of the brain where seizures originate, aiming to remove or alter it to prevent seizure activity. Epilepsy surgery has become increasingly refined with advancements in imaging, neuro-navigation, and minimally invasive techniques, providing patients with greater safety and improved outcomes. As a last-resort treatment option, epilepsy surgery offers hope to individuals for whom traditional therapies have proven ineffective.

The Epilepsy Surgery Market Size was valued at USD 980 million in 2022 and is expected to reach USD 1483.5 million by 2030 and grow at a CAGR of  5.32% over the forecast period 2023-2030.

Future Scope

The future of epilepsy surgery is promising, with ongoing research focusing on minimally invasive techniques, neurostimulation, and robotics to enhance precision. Advances in pre-surgical imaging and diagnostic tools, such as high-resolution MRI and intracranial EEG monitoring, are expected to improve patient selection and outcome prediction, making epilepsy surgery safer and more accessible. Neurostimulation, in particular, is gaining attention as a potential non-destructive alternative that modulates brain activity without removing tissue. These advancements will likely expand the surgical options available, bringing improved seizure control to a broader range of patients.

Trends

Recent trends in epilepsy surgery include the increased use of minimally invasive techniques, such as laser ablation and stereoelectroencephalography (sEEG), which reduce recovery time and post-surgical complications. Another trend is the use of responsive neurostimulation (RNS) devices, which continuously monitor brain activity and deliver targeted electrical impulses to prevent seizure onset. Personalized approaches to epilepsy surgery are also on the rise, with tailored surgical plans based on individual brain mapping, enhancing the precision and efficacy of treatments.

Applications

Epilepsy surgery is used primarily in patients with focal epilepsy, where seizures originate from a localized area of the brain that can be surgically targeted. It is also used in treating severe forms of epilepsy, such as temporal lobe epilepsy, where medication fails to provide adequate control. Additionally, neurostimulation devices are being employed for patients who are not suitable candidates for resective surgery. Epilepsy surgery’s applications extend beyond seizure control, offering improvements in cognitive and psychosocial outcomes for patients, making it a life-changing intervention for those affected by severe epilepsy.

Key Points

Epilepsy surgery targets brain areas responsible for seizure activity in drug-resistant cases.

Future advancements focus on minimally invasive techniques and neurostimulation.

Trends include the use of laser ablation, sEEG, and RNS devices for precision and safety.

Applicable for focal epilepsy and temporal lobe epilepsy when medication is ineffective.

Improves quality of life by reducing seizures and enhancing cognitive outcomes.

Conclusion

Epilepsy surgery represents a life-changing solution for individuals with drug-resistant epilepsy, providing an opportunity for seizure reduction or elimination. With the continuous advancements in minimally invasive techniques and neurostimulation, epilepsy surgery is becoming more refined and accessible, offering improved safety and efficacy. As this field advances, it is anticipated that epilepsy surgery will bring hope to an even wider patient population, enabling individuals to achieve better seizure control and improved quality of life.

[hiddenfallsmedia01]

Neuromarketing Trends: Innovations Shaping the Future

Neuromarketing is transforming how companies understand and connect with consumers by leveraging consumer neuroscience to analyze brain responses to marketing stimuli. This scientific approach enables more effective, emotionally resonant marketing. Emerging trends include AI and machine learning, which enhance the depth of insights, and wearable devices like EEGs for real-time data. Virtual and augmented reality also simulate environments to track buyer responses. As technology advances, neuromarketing can foster personalized campaigns, aligning brand messages with individual preferences while respecting privacy. Hidden Falls Media uses cutting-edge neuromarketing strategies to benefit clients.

Click to know more about Neuromarketing Trends.

[exitrendmarkettrend]

Brain-Computer Interface Market: Transforming Healthcare, Communication, and Beyond

The Brain Computer Interface Market has been making waves in recent years, with a rapid evolution in both capability and application. This technology, which enables direct communication between the brain and external devices, is becoming increasingly important across various sectors. With a wide range of applications and a promising growth trajectory, the BCI market is positioned to be a transformative force in the coming decade.

1. Market Size and Growth

The global Brain-Computer Interface market was valued at $2.24 billion in 2023. With rapid advancements and an increasing interest across multiple industries, the market is projected to grow to $2.61 billion in 2024 and skyrocket to $6.68 billion by 2030. This represents a compound annual growth rate (CAGR) of 16.9% over the forecast period from 2024 to 2030.

This substantial growth highlights the rising demand for BCI technology and its evolving application in fields such as healthcare, communication, entertainment, and smart home control. As BCI solutions become more integrated into consumer and medical devices, they will drive growth across industries and regions.

2. Key Market Players

The BCI market includes numerous established companies and innovative startups that are pushing the boundaries of brain-computer interaction. Here are some of the prominent players:

Nihon Kohden Corporation: A leader in medical electronics, Nihon Kohden has contributed significantly to the development of non-invasive BCI technology for healthcare applications.

Mind Solutions: Known for its work in EEG headsets and thought-controlled software, Mind Solutions has made strides in communication and control applications.

Advanced Brain Monitoring: Focusing on medical applications, Advanced Brain Monitoring has pioneered devices for monitoring and assisting brain health.

Quantum Applied Science and Research: This company has developed advanced BCIs with applications in neuroscience research.

Cadwell Laboratories: Specializes in neurodiagnostic and neuromonitoring solutions, contributing to the development of non-invasive BCIs.

OpenBCI: A prominent name in open-source BCI technology, OpenBCI provides affordable and accessible BCI platforms for research and consumer use.

Cortech Solutions: Known for producing tools for neuroscience research, Cortech Solutions has a growing influence in BCI technology.

NeuroSky and Emotiv: These two companies lead in consumer-focused BCI devices, bringing the technology into the mainstream for entertainment and gaming.

Guger Technologies OEG: This company specializes in EEG hardware, making strides in non-invasive and medical BCI applications.

3. Key Segments of the BCI Market

BCI technology can be broadly categorized by type and application:

By Type

Invasive BCI: These BCIs involve implants placed directly into brain tissue to achieve a high level of precision. Although invasive BCIs pose surgical risks, they are particularly useful in treating severe neurological conditions and aiding those with paralysis.

Non-invasive BCI: Non-invasive methods, including EEG and fNIRS, are widely used due to their safety and accessibility. These BCIs have applications in healthcare monitoring, gaming, and smart home control.

Partially Invasive BCI: These involve devices placed on the surface of the brain rather than inside the tissue. Partially invasive BCIs offer a middle ground between precision and safety, useful in medical applications where some level of invasive procedure is acceptable.

By Application

Healthcare: BCI technology is transforming healthcare by enabling patients with neurological disorders to regain control over certain bodily functions. BCIs are used for rehabilitation, diagnostics, and prosthetic control.

Communication and Control: BCIs enable users to communicate through thoughts, providing a revolutionary tool for individuals with communication challenges. The technology also opens possibilities for controlling devices using brain signals, expanding applications in both personal and industrial settings.

Entertainment and Gaming: BCI in gaming has created interactive experiences where players can control elements of the game directly with their thoughts. This creates a unique experience in gaming and other forms of digital entertainment.

Smart Home Control: BCI is enhancing smart home automation by allowing users to operate devices like lights, locks, and appliances with their thoughts, making the home environment more accessible for those with physical limitations.

4. Regional Analysis

The BCI market is expanding worldwide, with key regions each contributing uniquely to its growth:

North America: The largest market for BCI technology, North America benefits from a strong healthcare infrastructure, high investment in research, and an early adoption culture. Key players based here drive innovation, making North America a leading market for both invasive and non-invasive BCI devices.

Europe: Europe is investing heavily in BCI for healthcare and medical applications. The region's support for research into neurological diseases and disabilities is propelling growth, with companies and institutions working together to advance non-invasive BCI technologies.

Asia Pacific: This region is experiencing rapid growth due to increased government funding in technology and healthcare infrastructure. Rising consumer awareness and adoption of smart technologies make Asia Pacific a promising market for BCI in both medical and non-medical applications.

Latin America: With growing investments in digital health, Latin America is an emerging market for BCI technologies. Efforts are underway to introduce affordable BCI solutions, particularly in communication and healthcare.

Middle East & Africa: As healthcare infrastructure develops, there is an increasing interest in BCI applications for medical use. Though still a smaller market, the Middle East & Africa show potential, especially in regions focused on high-tech medical solutions.

5. Future Outlook and Trends

With the continued evolution of technology, several trends are shaping the future of the BCI market:

Advancements in AI Integration: Artificial intelligence is enhancing BCI capabilities, particularly in interpreting complex brain signals. AI algorithms can analyze brain data in real-time, which is essential for applications requiring immediate responses, such as gaming or emergency healthcare.

Increased Focus on Non-Invasive Solutions: Given the complexities of invasive BCIs, there is a growing emphasis on enhancing the performance and usability of non-invasive devices. Research is making strides in improving the accuracy and responsiveness of non-invasive BCIs, potentially making them more effective across various applications.

Growing Application in Rehabilitation: BCI technology in rehabilitation is expected to grow, with BCI-based devices helping stroke and spinal injury patients regain motor function. By connecting brain signals to prosthetics, BCIs can assist in restoring independence for those with motor disabilities.

BCI in Mental Health Monitoring: Monitoring mental health through BCIs is an emerging trend. By tracking brain activity related to stress, anxiety, or depression, BCI technology could play a crucial role in early detection and intervention in mental health care.

Consumer Electronics Integration: With increasing demand for user-friendly interfaces in consumer electronics, BCI technology could become a part of everyday devices. Wearables with BCI integration may allow users to control music, adjust settings, or communicate with other devices simply by thought.

6. Challenges in the BCI Market

Despite its promising outlook, the BCI market faces some hurdles:

Ethical Concerns: As BCIs can access and interpret brain data, there are concerns over privacy and data security. Clear regulations and ethical guidelines are necessary to protect users' mental privacy.

Technical Limitations: Decoding brain signals accurately and in real-time remains a challenge. Misinterpretation of signals can hinder the effectiveness of BCIs, especially in critical applications such as healthcare.

High Costs and Accessibility: BCI technology is expensive, limiting its accessibility. As more affordable options emerge, especially in non-invasive BCI, the market could see wider adoption.

7. Conclusion

The Brain-Computer Interface market is poised for exponential growth over the next decade, driven by technological advancements, diverse applications, and a rising demand for more integrated, interactive systems. By 2030, BCIs could become a regular part of healthcare, consumer electronics, and even daily communication, reshaping how humans interact with machines. As key players continue to innovate and regions invest in research and development, the BCI market will undoubtedly play a crucial role in the future of human-computer interaction.

Browse More:

Botulinum Toxin Market Analysis

[farmacuticals]

Sculpting Synapses: How Plastics are Redefining Neuroscience Applications

The Neuroscience Market encompasses the study of the nervous system and its impact on behavior and cognitive functions. This field covers a broad spectrum of scientific areas, from molecular and cellular studies to brain imaging and computational neuroscience. The global Neuroscience Market is expected to witness significant growth due to advancements in technology, increased investment in research, and a rising prevalence of neurological disorders such as Alzheimer's, Parkinson's, and epilepsy. The emergence of innovative diagnostic tools and treatments is also driving market expansion.

The Neuroscience Market was projected by MRFR analysis to reach 35.4 (USD Billion) in 2022. The market for neuroscience is predicted to increase from 36.9 billion USD in 2023 to 53.9 billion USD in 2032. Throughout the projection period (2024–2032), the neuroscience market's compound annual growth rate (CAGR) is projected to be about 4.3%.

The Neuroscience Market is particularly essential for understanding complex brain functions and the mechanisms underlying neurological diseases. With increased government funding, academic research, and collaboration between private and public sectors, the industry is poised for sustained growth. The growing demand for novel therapeutic approaches and diagnostics in treating neurological disorders continues to influence the dynamics of the Neuroscience Market, promoting further research and development.

Neuroscience Market Size

The size of the Neuroscience Market is projected to grow significantly in the coming years. As of 2023, the market was estimated at several billion dollars and is forecasted to grow at a compound annual growth rate (CAGR) of around 4-6% over the next decade. The market size is expected to expand due to technological advancements such as brain imaging techniques, neuromodulation devices, and wearable neurotech devices. These tools are transforming the way we diagnose and treat neurological disorders, thereby fueling the demand in the Neuroscience Market.

Increasing healthcare expenditures, rising awareness about mental health and neurological diseases, and the growing aging population contribute to the increase in Neuroscience Market size. Additionally, pharmaceutical companies are focusing on neuroscience research for developing new drugs and therapies, boosting the overall market.

Neuroscience Market Share

The Neuroscience Market share is divided among several key players who are involved in developing technologies, tools, and treatments for various neurological conditions. Major companies in the Neuroscience Market include Abbott, General Electric Healthcare, Siemens Healthineers, and Medtronic. These companies hold a significant portion of the Neuroscience Market share due to their continuous innovations in imaging techniques, neurostimulation devices, and research into neurodegenerative diseases.

The academic sector also plays a substantial role, contributing to neuroscience research and advancing scientific knowledge through collaborations with industry giants. The pharmaceutical and biotechnology industries further dominate the market share by investing in drug discovery and therapeutic development for conditions like depression, schizophrenia, and neurodegenerative diseases. Emerging startups focusing on neuroinformatics, brain-computer interfaces, and artificial intelligence applications are also gaining a share in the market.

Neuroscience Market Trends

Several key trends are shaping the future of the Neuroscience Market. First, advancements in neuroimaging technologies such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and magnetoencephalography (MEG) are enabling more precise diagnostics and better understanding of brain disorders. Second, the integration of artificial intelligence and machine learning in neuroscience is transforming data analysis, accelerating research, and allowing personalized treatment plans.

Third, the rise of wearable neurotechnology devices, such as brain-sensing headsets, is a growing trend in the Neuroscience Market. These devices are being used for monitoring brain activity in real time, which is valuable for both clinical research and therapeutic applications. Fourth, gene therapy and stem cell research are rapidly progressing, offering potential breakthroughs in treating neurodegenerative diseases. Lastly, the increasing focus on mental health, especially post-pandemic, is driving the demand for neuroscience-based treatments and solutions for anxiety, depression, and stress-related disorders.

Reasons to Buy Neuroscience Market Reports

Comprehensive Market Insights: The report provides in-depth insights into the global Neuroscience Market, including market size, share, growth trends, and key drivers.

Forecasting and Analytics: Neuroscience Market reports offer future projections and forecasts, enabling businesses to make informed decisions regarding investments and strategies.

Competitive Landscape: Detailed analysis of the key players in the market, including their product portfolios, business strategies, and recent developments, is provided in the reports.

Emerging Trends: Reports highlight the latest trends in neuroscience research, technological advancements, and emerging applications that are expected to shape the market's future.

Strategic Recommendations: The reports offer actionable insights and recommendations for stakeholders, helping them navigate challenges and leverage opportunities in the Neuroscience Market.

Recent Developments in the Neuroscience Market

Recent developments in the Neuroscience Market have been driven by advancements in both academic research and commercial applications. For example, there has been significant progress in non-invasive brain stimulation technologies such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). These methods are being explored as potential treatments for conditions like depression and chronic pain.

Additionally, brain-computer interface (BCI) technology is making strides, with companies like Neuralink working on direct brain interfaces that could revolutionize how we interact with machines. The development of more sophisticated brain imaging tools and computational models of the brain has also accelerated neuroscience research, making it possible to tackle previously untreatable brain disorders.

In conclusion, the Neuroscience Market is growing rapidly due to technological innovations, increased research funding, and a greater understanding of neurological conditions. With more developments on the horizon, this market presents substantial opportunities for investment and research.

Related reports:

Vascular Access Device Market

Veterinary Chemistry Analyzer Market

Veterinary Endoscope Market

[siliconsignalsblog]

How Different Industries Are Being Transformed by Embedded Systems

An embedded system is an integrated system in which firmware or hardware has software built in to carry out particular functions. It has one or more microprocessors, each of which can run a collection of programs that are stored in memory and defined during the design process. It's an electronic system that we can program to meet our needs and specifications. Development platforms, software, and hardware are all included in embedded systems. The most effective way for embedded systems to operate is without human intervention. Embedded systems have advanced our lives since their inception by providing comfort, accessibility, and connectivity.

In recent years, the global market for embedded systems has experienced a significant evolution in terms of usage. Embedded systems technology has greatly expanded the world of connected and intelligent IoT ecosystems with IoT and Industrial IoT (IIoT). Embedded systems are used in a wide range of industries, goods, and services. The automotive, aerospace, communications, military, and consumer electronics sectors are just a few of the industries that make up the embedded systems market. Development platforms, testing, real-time operating systems (RTOS), and other software components make up embedded systems. The printed circuit boards, firmware, and other components make up the hardware.

Let's look into the impact that embedded systems have on different industries.

Embedded systems in the Automotive Industry.

Embedded systems make up the majority of this industry and are used extensively in automotive applications. Embedded systems are used in the vehicle for all system control, maintenance, security, audio systems, pollution control, energy efficiency, and driver awareness. In addition, navigation systems, adaptive cruise control—also referred to as driverless cars—automated parking systems, airbag control systems, and anti-lock braking systems all use embedded systems. The way cars are designed and made today has been completely transformed by embedded systems, which are renowned for their adaptability and flexibility.

Embedded systems in the Healthcare Industry.

Without a doubt, embedded systems have a significant impact on the healthcare sector. X-ray machines, pulse oximeters, EEG, ECG, CT, electronic defibrillators, glucose monitors, scanning devices, PET scanners, imaging systems, diagnostic equipment, etc. all use embedded systems. Moreover, a portable embedded system aids in heart rate monitoring and artery blockage detection. Because of the embedded system's increased functionality and intelligence, embedded technologies are also utilized for complex and intricate surgeries. Robotic arms and remote surgery technologies are used to treat patients through embedded systems. The quality of life for people seeking at-home healthcare is greatly improved by modern embedded systems.

Embedded systems in the Consumer Electronics Industry 

Embedded systems are extensively utilized in a wide range of everyday consumer electronics products. For instance, keyboards, mice, and other components of computer systems; TVs; digital cameras; fax machines; music players; video game consoles; digital watches; dishwashers; home appliances; printers; home security systems; and so on. Certain embedded systems found in consumer electronics gather data and use it to control appliances in accordance with user commands. Additionally, certain sensors are employed to gather data about the operation of the application and transmit it to the appropriate sources.

Embedded systems in Industrial Automation

Automation benefits greatly from embedded systems, which are well suited for industrial automation applications like vehicles, irrigation, agricultural automation, and GPS and satellite-guided planting, fertilization, and harvesting. Construction, mining, oil and gas production, logistics and warehouse management, smart factories, and manufacturing. Artificial Intelligence (AI), machine learning, and embedded intelligence are used by embedded systems to provide self-healing systems, access control, and environmental monitoring and maintenance.

Silicon Signals is a prominent embedded company based in India. Please subscribe to our blog to learn more about embedded systems and embedded product design. For any sales-related inquiries, please call +91 98798 60944. We can also be reached by email at sales@signals.io, and we will be pleased to help.

[marketsreport]

Electroencephalogram (EEG) equipment is widely utilized to monitor the electrical activity of the brain. It relies on electrodes, amplifiers, filters and an analog to digital converter to record brain wave patterns and send the data to a computer or cloud device. It finds application in diagnosing conditions, such as seizures, epilepsy, head injuries, dizziness, headaches, brain tumors and sleeping disorders. On the other hand, electromyography (EMG) equipment helps evaluate the electrical activity in skeletal muscles. 

[deshpandeisha]

Refurbished Medical Equipment Market Growth and Size for Strategic Decision-Making

The global refurbished medical equipment market size is expected to reach USD 45.81 Billion in 2032 and register a steady revenue CAGR of 11.8% during the forecast period, according to latest analysis by Emergen Research. Increasing preference for eco-friendly products is a major factor driving market revenue growth of. Benefits of used medical imaging equipment for environment must be emphasized.

The circular economy is supported by refurbishment, a sort of reuse and waste reduction that raises useful lifespan of medical imaging equipment from 5-7 to 10-14 years or even longer. Resources and energy required to produce new equipment are saved by refurbishment. It is critical from an environmental standpoint to maximize service life of imaging scanners due to energy and materials used throughout the production, safety testing, and regulatory compliance processes. For instance, improving Magnetic Resonance Imaging (MRI) scanners and extending their service life maximizes the return on initial investment of energy and materials.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1748

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Refurbished Medical Equipment market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

GE HealthCare, Koninklijke Philips N.V., Siemens Healthcare GmbH, Block Imaging, Inc., Soma Tech INTL, Avante Health Solutions, Hilditch Group, EverX Pty. Ltd., Integrity Medical Systems, Inc., and Radiology Oncology Systems

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/refurbished-medical-equipment-market

Emergen Research has segmented the global Refurbished Medical Equipment market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Product Outlook (Revenue, USD Billion; 2019–2032)

Medical Imaging Equipment

Computerized Tomography (CT) Scanners

Magnetic Resonance Imaging (MRI) Machines

X-Ray Machines

Nuclear Imaging Systems

Ultrasound Systems

Other Medical Imaging Equipment

Operating Room & Surgical Equipment

Anesthesia Machines

Electrosurgical Units

Operating Room Tables & Lights

Surgical Displays

Other Operating Room & Surgical Equipment

Patient Monitors

Multi-Parameter Monitors

Fetal Monitors

Electrocardiography Devices

Pulse Oximeters

Mobile Cardiac Telemetry Devices

Non-Invasive Blood Pressure Monitors

Other Patient Monitors

Cardiology Equipment

Defibrillators

Heart-Lung Machines

Other Cardiology Equipment

Urology Equipment

Dialysis Machines

Lithotripsy Devices

Neurology Equipment

Electromyograph Machines (EMG) Machines

Electroencephalography (EEG) Machines

Intensive Care Equipment

Ventilators

Infant Incubators & Warmers

Intravenous Therapy Systems

Endoscopy Equipment

Other Medical Equipment

Application Outlook (Revenue, USD Billion; 2019–2032)

Diagnostic Applications

Cardiology

Urology

Neurology

Orthopedics

Physiology

Emergency Medicine

Oncology

Obstetrics/Gynecology

Other Diagnostic Applications

Therapeutic Applications

Cardiology

Urology

Neurology

Orthopedics

Physiology

Emergency Medicine

Oncology

Obstetrics/Gynecology

Other Therapeutic Applications

End-Use Outlook (Revenue, USD Billion; 2019–2032)

Hospitals

Diagnostic Imaging Centers

Ambulatory Care Centers

Other End-Use

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Refurbished Medical Equipment Market size and share for the projected period of 2022-2030

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Refurbished Medical Equipment Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1748

[poonamcmi]

Neurodiagnostics Market Estimated to Witness High Growth Owing to Growing Geriatric Population

​The neurodiagnostics market plays a crucial role in neurological disease diagnosis and treatment monitoring. Neurological disorders such as epilepsy, Alzheimer's disease, Multiple Sclerosis, Parkinson's disease, and other neurological conditions are becoming increasingly prevalent. Neurodiagnostics help detect neurological abnormalities through neurological imaging such as MRI, EEG, and diagnostic tests. The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics.

The Global Neurodiagnostics Market is estimated to be valued at US$ 8.66 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 To 2031.

Key Takeaways Key players operating in the neurodiagnostics are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.

The Neurodiagnostics Market Trends  include increasing investments in R&D for biomarker-based disease diagnosis and neuroimaging. The global expansion of key players through mergers and acquisitions will further aid market growth.

The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics. Furthermore, increasing investments in R&D by key players for developing advanced diagnostic systems will boost the neurodiagnostics market over the forecast period.

Market drivers The growing geriatric population is the major driver propelling the Neurodiagnostics Market Size And Trends As per the United Nations, people aged over 60 years are projected to outnumber children under 10 years by 2050. Elderly people are more vulnerable to neurological disorders like Alzheimer's and Parkinson's disease. This will augment the demand for neurodiagnostics for early disease diagnosis and treatment monitoring. Increasing awareness about brain health and availability of reimbursement policies for neurodiagnostic tests will also boost market revenues significantly over the forecast period.

PEST Analysis Political: Regulations related to medical devices and neurological disorder treatments have an impact. Reimbursement policies by governments and insurance agencies also affect market growth. Economic: The growing insurance coverage levels and disposable incomes have boosted healthcare spending including on neurodiagnostics. Higher investments in clinical trials and R&D remain crucial. Social: Rising prevalence of neurological disorders like Alzheimers, Parkinsons, epilepsy, and stroke is a key driver. Growing awareness encourages early diagnosis through imaging techniques. Technological: Advancements in imaging modalities like MRI, CT, PET, EEG, and newer technologies like digital EEG and MEG expands diagnosis capabilities. Portable and wearable devices improve accessibility.

Geographical Regions with High Market Concentration North America accounts for the largest share in the neurodiagnostics market in terms of value, owing to the presence of major players, high healthcare expenditure, and rising neurological disorders. The United States holds a significant share in the regional market.

Fastest Growing Regional Market The Asia Pacific region is expected to witness the highest growth in the neurodiagnostics market during the forecast period. This is attributed to factors such as growing healthcare expenditure, increasing healthcare infrastructure development, and rising geriatric population in the region suffering from neurological conditions. Rapidly developing countries like China and India with huge patient pools offer high growth potential. Get More Insights On, Neurodiagnostics Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[credenceresearchdotblog]

The global demand for Brain Health Devices was valued at USD 11254.20 million in 2023 and is expected to reach USD 16724.81 million in 2032, growing at a CAGR of 4.50% between 2024 and 2032.The brain health devices market is witnessing significant growth, driven by increasing awareness of neurological disorders, advancements in technology, and a growing aging population. These devices, designed to monitor, diagnose, and treat brain-related conditions, are becoming indispensable tools in both clinical and home settings. This article explores the key drivers, trends, and future prospects of the brain health devices market.

Browse the full report at https://www.credenceresearch.com/report/brain-health-devices-market

Market Drivers

1. Rising Prevalence of Neurological Disorders: The global incidence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is on the rise. According to the World Health Organization (WHO), neurological disorders are a major cause of disability and death worldwide. This has created a pressing need for effective diagnostic and therapeutic solutions, fueling the demand for brain health devices.

2. Technological Advancements: Innovations in technology have led to the development of more sophisticated and accurate brain health devices. For instance, advancements in neuroimaging techniques, such as functional MRI (fMRI) and positron emission tomography (PET), have revolutionized the way neurological conditions are diagnosed and monitored. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in these devices has enhanced their predictive capabilities, enabling early diagnosis and personalized treatment plans.

3. Aging Population: The global population is aging, with a significant increase in the number of individuals over the age of 60. This demographic is more susceptible to neurological disorders, driving the demand for brain health devices. According to the United Nations, the number of people aged 60 and above is expected to double by 2050, highlighting the growing market potential.

4. Increased Awareness and Government Initiatives: Public awareness about brain health and neurological conditions has improved significantly, partly due to various government initiatives and campaigns. Programs aimed at educating the public and healthcare professionals about early detection and management of neurological disorders have played a crucial role in market growth. Additionally, favorable government policies and funding for research and development in the field of neuroscience have further propelled the market.

Market Segmentation

1. By Product Type: - Neurostimulation Devices: These include deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators, which are used to treat conditions like Parkinson’s disease and epilepsy. - Neurodiagnostic Devices: This category encompasses electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, and near-infrared spectroscopy (NIRS) devices, used for diagnosing and monitoring neurological disorders. - Neurorehabilitation Devices: These devices, such as brain-computer interfaces (BCIs) and robotic systems, are designed to aid in the rehabilitation of patients with neurological impairments.

2. By End-User: - Hospitals and Clinics: These facilities are the primary users of brain health devices, given their capability to provide comprehensive diagnostic and therapeutic services. - Home Care Settings: With the advent of portable and user-friendly devices, there is a growing trend towards home-based monitoring and treatment of neurological conditions. - Research and Academic Institutes**: These institutions utilize brain health devices for conducting research and developing new treatment methodologies.

Regional Insights

The brain health devices market is geographically segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

- North America: This region dominates the market due to advanced healthcare infrastructure, high healthcare expenditure, and significant investments in R&D. The presence of major market players and favorable reimbursement policies also contribute to market growth. - Europe: Europe holds a significant share of the market, driven by increasing prevalence of neurological disorders and robust healthcare systems. - Asia-Pacific: This region is expected to witness the fastest growth, attributed to rising awareness, improving healthcare infrastructure, and increasing healthcare expenditure in countries like China and India.

Future Prospects

The future of the brain health devices market looks promising, with continuous advancements in technology and growing investment in neurological research. Personalized medicine, driven by AI and big data analytics, is expected to revolutionize the field, offering tailored treatment plans for individuals based on their genetic and environmental profiles. Additionally, the integration of brain health devices with wearable technology and mobile health applications is likely to enhance patient engagement and adherence to treatment protocols.

Key Players

BrainScope Company, Inc.

Bio-Signal Group Corp.

Cadwell Industries, Inc.

Advanced Brain Monitoring, Inc.

Compumedics Ltd.

Elekta

DePuy Synthes

Electrical Geodesics, Inc.

Medtronic

GE Healthcare

MEG International Services Ltd.

Natus Medical, Inc.

Neurowave Systems Inc.

Nihon Kohden Corporation

Philips Healthcare

Segmentation

By Neurostimulation Devicess

Deep Brain Stimulation (DBS) Devices

Transcranial Magnetic Stimulation (TMS) Devices

Vagus Nerve Stimulation (VNS) Devices

By Neuroimaging Devices

MRI Scanners

CT Scanners

PET and SPECT Scanners

By Neurosurgical Devices

Neurosurgical Navigation Systems

Neuroendoscopes

Cerebrospinal Fluid (CSF) Shunts

By Brain Monitoring Devices

EEG Monitors

Cerebral Oximeters

Intracranial Pressure Monitors

By Neurocognitive Assessment Devices

Neuropsychological Test Batteries

Virtual Reality Platforms

Brain-Computer Interface Systems

By Region

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/brain-health-devices-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[themarketupdate]

Consumer Level EEG Device Market Outlook: World Approaching Demand & Growth Prospect 2024-2030

An electroencephalogram (EEG) is a test used to evaluate the electrical activity in the brain. Brain cells communicate with each other through electrical impulses. An EEG can be used to help detect potential problems associated with this activity. The factors contributing to the growth of the consumer level EEG device market are the rising development of wearable EEG devices and a growing number of players operating across the country conferring the highest manufacturing of the wearable EEG devices. Furthermore, the presence of supportive government initiatives and research in the field of neurology also boosts the market growth.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/51121-global-consumer-level-eeg-device-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Consumer Level EEG Device Market, offers a detailed overview of the factors influencing the global business scope. Consumer Level EEG Device Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Consumer Level EEG Device The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Advanced Brain Monitoring, Inc. (United States), ANT Neuro (Netherlands), Natus Medical Incorporated (United States), Brain Products GmbH (Germany), Compumedics Neuroscan (Australia), Electrical Geodesics, Inc. (Koninklijke Philips N.V.) (Netherlands), EMOTIV (United States), g.tec medical engineering GmbH (Austria), Neuroelectrics (Spain), Cadwell Industries, Inc. (United States)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[healthcarehubhh]

The brain health devices market will grow at highest pace owing to increasing awareness of brain related diseases and technological advancements in diagnostics devices

Brain health devices aid in the diagnosis and treatment of brain related disorders by leveraging technologies like electroencephalography (EEG), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), and intracranial pressure monitoring (ICP). These devices help understand patterns of neuronal activity, functional connectivity, and brain dynamics. The BrainScope Company's portable EEG device analyzes brain waves and classifies them to help diagnose brain injuries and concussions within minutes. Brain health devices are increasingly being used in hospitals, neuro laboratories and clinics to gain meaningful insights and devise personalized treatment plans for patients suffering from Alzheimer's, Parkinson's, epilepsy, strokes and dementia. The Global Brain Health Devices Market is estimated to be valued at US$ 9,070.5 million in 2024 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the brain health devices market are BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc., Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic, GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare. Growing awareness regarding various brain related diseases and disorders is expected to propel the demand for brain health devices over the forecast period. Technological advancements are enabling high resolution scanning of brain structural and functional connectivity networks through lightweight and portable devices. Market Trends Portable and Home-Use Devices: Growing demand for convenient medical devices is prompting manufacturers to develop portable and wireless EEG, MEG, TMS and ICP monitoring equipment that can be used at home. This makes treatment accessible and inexpensive. Artificial Intelligence Integration: AI and machine learning techniques are finding widespread usage in brain data analysis. Devices are being integrated with AI capabilities to offer real-time diagnostics, automated report generation and personalized treatment recommendations. Market Opportunities Paediatric Applications: Brain monitoring and therapeutic devices tailored for infants and children can help diagnose developmental delays and disorders early. This presents lucrative opportunities. Emerging Markets: There is significant untapped growth potential in developing regions of Asia Pacific, Latin America, Middle East and Africa driven by rising healthcare expenditures and increasing incidence of neurological conditions. Impact of COVID-19 on Brain Health Devices Market The COVID-19 pandemic has accelerated the growth of the brain health devices market. Hospitals and diagnostic centers witnessed a surge in demand for brain monitoring devices due to the rising number of COVID-19 patients. Neurological complications were prevalent among severe COVID cases, necessitating effective brain monitoring. Further, risk factors of strokes and mental health issues increased amid lockdowns and social isolation, propelling the need for brain health management devices for diagnosis and treatment. The pandemic led to challenges in the supply chain and distribution channel initially. However, companies introduced new product lines specific to COVID care and virtually connected healthcare models utilizing brain health devices. The focus on portable, home-used devices for conditions like alzheimers, dementia, headaches, and insomnia aided market prospects. Telehealth emerged as an efficient mode to serve patients from remote locations as they avoided visits to crowded hospitals, especially during the peak pandemic periods.

[tritonmarketresearchamey]

Epilepsy Devices Market: Tech Trends 2022-2028

According to the WHO, epilepsy is a chronic brain disorder that affects 50 million individuals, making it one of the most prevalent neurological conditions worldwide. It is estimated that with access to early detection and appropriate care, 70% of the population diagnosed with epilepsy may live seizure-free. According to our estimates, the global epilepsy devices market was valued at $669.73 million in 2021 and is expected to reach $1157.58 million by 2028, growing at a CAGR of 8.16% during the forecast period 2022-2028.

Government institutions worldwide are focused on starting initiatives to create innovative epilepsy devices with AI and machine learning integration. Additionally, organizations that support research need to encourage high-quality comparative efficacy trials and sufficient data to guide therapeutic practice in epilepsy. As a result of these technologically advanced equipment and increasing drug trials, the market for epilepsy devices is anticipated to grow throughout the forecast period.

Epilepsy Devices - Key Detection Methodologies

Currently, several wearable technologies can detect seizures, collect data, and alert caregivers. Although with technological advancements, the ability to detect seizure-related alterations increases. Top trends backing this tech boom include:

Wearable devices are estimated to be the fastest-growing device type during the forecast period. Monitoring epileptic patients is crucial, as 20% of epileptics only have seizures while asleep, 40% only have seizures while awake, and 35% have seizures both when they are awake and asleep. With technologically advanced non-invasive wearable sensors, measuring accelerometry, photoplethysmography (PPG), electrodermal activity (EDA), electromyography (EMG), and other signals outside of the conventional clinical environment have become effective.

Vagus Nerve Stimulation (VNS) has emerged as the fastest-growing application category. VNS Therapy has been approved by the U.S. Food and Drug Administration (FDA) as an add-on therapy for age 4 years and above to treat drug-resistant epilepsy or refractory epilepsy. VNS has been reportedly beneficial in many patients, including the ones with posttraumatic epilepsy (PTE). PTE is a common consequence of traumatic brain injury and accounts for about 20% of symptomatic epilepsy cases.

As per estimates, Electroencephalography lead the detection and prediction devices type segment in 2021 and is expected to maintain its stronghold during the forecast period. There is growing interest in wearable or mobile EEG solutions that allow long‐term EEG monitoring in an easy‐to‐use format. Despite the availability of these new EEG solutions, their adoption is still limited in clinical practice, mainly because of the unfamiliarity of healthcare and biomedical research sectors with the technology and its application.

Strategic Initiatives and Government Approvals

Different end-users, such as homecare settings, hospitals, and clinics, are utilizing epilepsy devices. The manufacturers of epilepsy monitoring devices are likely to gain prominent business opportunities from the hospital & clinics segment owing to the rise in the use of EEG monitoring and emergency medical services.

The government authorities of several developing nations, including India and China, are focusing on developing sturdy healthcare infrastructure. As a result, operating players are expected to gain sizable growth prospects in the region during the forecast period. Owing to this, the Asia Pacific epilepsy devices market is anticipated to witness the fastest growth with a CAGR of 8.38% throughout the forecast period.

In addition, companies are also focusing on launching novel devices for children. Moreover, companies are also using organic and inorganic strategies, including mergers and acquisitions, to stay ahead of the competition. Some of these include:

In September 2022, Boston Scientific Corporation’s current-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling. The company also received FDA 510(k) clearance for the EMBOLD Fibered Detachable Coil, which reduces the blood flow rate in the peripheral vasculature.

In July 2022, Medtronic PLC received FDA 510(k) clearance for its UNiD Spine Analyzer v4.0 planning platform to leverage machine learning.

In November 2021, NeuroPace, Inc. received an Investigational Device Exemption (IDE) from the FDA to study the company’s RNS System to treat primary generalized epilepsy in patients aged 12 and above.

Way Forward

With technological advancements, epilepsy detection devices with exceptionally low false alarm rates have recently been developed. They are based on computationally intensive algorithms and employed in implanted systems for pre-surgical monitoring. Recent research has produced encouraging findings for probabilistic seizure risk projections using long-term wearable technology and electronic seizure diaries. The symptoms, mood, and cognitive function of an individual may also have predictive significance. Therefore, technological advances in non-invasive wearable sensors are anticipated to create growth opportunities for the epilepsy devices market.

 

FAQ:

Q1) What are the key end-users of the epilepsy devices market?

The key end-users in the epilepsy devices market include hospitals & clinics, neurology centers, homecare settings, and other end-users.

Q2) Which region leads the global epilepsy devices market?

North America leads the global epilepsy devices market.